
Aurobindo Pharma Gets USFDA Approval for Icatibant Injection
August 18, 2023
A significant achievement for Aurobindo Pharma emerges as its wholly-owned subsidiary, Eugia Pharma Specialities, gains the final green light from the US health authority for the production and distribution of a generic Icatibant injection. This injection is integral in addressing








